Phase 4 Neutropenia Clinical Trials
5 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–5 of 5 trials
Recruiting
Phase 4
Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens
Febrile Neutropenia
Beneficência Portuguesa de São Paulo176 enrolled1 locationNCT06342115
Recruiting
Phase 4
Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
NeutropeniaCytomegalovirus InfectionsInfection in Solid Organ Transplant Recipients+1 more
Tufts Medical Center25 enrolled1 locationNCT05626530
Recruiting
Phase 4
Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints
Chemotherapy-Induced Febrile Neutropenia
Qilu Pharmaceutical Co., Ltd.336 enrolled1 locationNCT06616571
Recruiting
Phase 4
Adjustment of Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Augmented Renal Clearance
Febrile Neutropenia
Centre Hospitalier Universitaire Vaudois30 enrolled1 locationNCT06293677
Recruiting
Phase 4
Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia
Neutropenia, Febrile
Universitaire Ziekenhuizen KU Leuven410 enrolled1 locationNCT05926063